Pure Bioscience (PURE)
Add to Watchlists Create an Alert
0.3652
+0.00 +0.00%
NASDAQ
May 24, 8:00PM
BATS Real time
Currency in USD
Pro Data Export
Pure Bioscience Key Statistics
Currency in USD
Current Valuation
Dividends and Shares
| Shares Outstanding | 10.99M |
| Dividend | |
| Dividend Yield | 0.00% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Latest Dividend Date | |
| Latest Ex-Dividend Date | |
| Last Split Factor | 0.125 |
| Last Split Date | Aug. 15, 2012 |
Profitability
| Gross Profit Margin Quarterly | 78.33% |
| Profit Margin Quarterly | -693.5% |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 1.655 |
| Debt to Equity Ratio | 0.7457 |
| Free Cash Flow | |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | -27.68% |
| Year to Date Stock Returns | -40.63% |
| 1 Year Stock Returns | -83.70% |
| 3 Year Stock Returns | -98.59% |
| 52 Week High | 3.992 |
| 52 Week Low | 0.3652 |
Income Statement
Cash Flow Statement
| Cash from Financing TTM | |
| Cash from Investing TTM | |
| Cash from Operations TTM | |
| Capital Expenditures Quarterly Pro | Go Pro |
Balance Sheet
| Cash and ST Investments | 0.92M |
| Long Term Debt | 1.299M |
| Total Assets | 4.127M |
| Liabilities | 2.385M |
| Shareholders Equity | 1.742M |
| Book Value | 1.742M |
| Book Value Per Share | 0.1586 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
PURE News
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PURE | 0.3652 | +0.00 | +0.00% |
New watchlist
